NNovartis Read More European Commission approves Novartis’ Itvisma to treat SMA2026-07-03 The European Commission has granted approval for Novartis’ Itvisma (onasemnogene abeparvovec) as a treatment for children two years…
NNovartis Read More European Commission approves Novartis’ Itvisma to treat SMA2026-07-03 The European Commission has granted approval for Novartis’ Itvisma (onasemnogene abeparvovec) as a treatment for children two years…